Literature DB >> 401530

Prolactin deficiency in pseudohypoparathyroidism.

H E Carlson, A S Brickman, G F Bottazzo.   

Abstract

Because thyrotropin deficiency may occur in pseudohypoparathyroidism, we studied pituitary function in two families with this condition. Six of eight patients had impaired pituitary prolactin secretion after administration of thyrotropin-releasing hormone and chlorpromazine, with preservation of other anterior pituitary functions. Peak serum prolactin levels after thyrotropin-releasing hormone and chlorpromazine in the prolactin-deficient patients were significantly lower than normal. Administration of diethylstilbestrol for five days, which normally enhances prolactin responses to thyrotropin-releasing hormone, had no effect on prolactin secretion in these patients. Although antilactotroph antibodies were not demonstrable, hypothyroidism or decreased thyroid reserve in four and antithyroid and antiparietal-cell antibodies in several family members suggest that an associated autoimmune process may be responsible for the prolactin deficiency.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 401530     DOI: 10.1056/NEJM197701202960304

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  11 in total

Review 1.  Prolactin: role in health and disease.

Authors:  D F Horrobin
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

2.  Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity.

Authors:  Z Farfel; V M Brothers; A S Brickman; F Conte; R Neer; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

3.  Diminished prolactin reserve with myotonic dystrophy.

Authors:  P B May; A Renny; J Bastek; W Giglio; G Schneider; N Ertel
Journal:  J Endocrinol Invest       Date:  1980 Oct-Dec       Impact factor: 4.256

4.  [Pseudohypoparathyroidism and adrenal cortex insufficiency. A case of multiple endocrinopathy due to peripheral hormone resistance].

Authors:  P Ridderskamp; R Schlaghecke
Journal:  Klin Wochenschr       Date:  1990-09-14

5.  Impaired formation of beta-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism.

Authors:  J A Heinsimer; A O Davies; R W Downs; M A Levine; A M Spiegel; M K Drezner; A De Lean; K A Wreggett; M G Caron; R J Lefkowitz
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

6.  Familial pseudohypoparathyroidism without somatic anomalies.

Authors:  J S Winter; I A Hughes
Journal:  Can Med Assoc J       Date:  1980-07-05       Impact factor: 8.262

7.  Multiple associated endocrine abnormalities in a patient with pseudohypoparathyroidism type 1a.

Authors:  M Shima; O Nose; K Shimizu; Y Seino; H Yabuuchi; T Saito
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

Review 8.  Nicotinic acid: an old drug with a promising future.

Authors:  E T Bodor; S Offermanns
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

9.  Prolactin deficiency, obesity, and enlarged testes--a new syndrome?

Authors:  A Roitman; S Assa; R Kauli; Z Laron
Journal:  Arch Dis Child       Date:  1980-08       Impact factor: 3.791

10.  Pseudopseudohypoparathyroidism associated with idiopathic growth hormone deficiency. Role of treatment with biosynthetic growth hormone.

Authors:  R Manfredi; A Zucchini; L Azzaroli; G Manfredi
Journal:  J Endocrinol Invest       Date:  1993-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.